Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme

Award Number: R01AI179465
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/21/2024
PERIOD OF PERFORMANCE END DATE: 04/30/2029

Group Awards By:

View Award Description

Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme - PROJECT SUMMARY Human APOBEC3 enzymes, particularly APOBEC3D, APOBEC3F, APOBEC3G, and stable haplotypes of APOBEC3H, can induce G>A mutations in the HIV-1 genome. Often, these mutations, particularly those inflicted by APOBEC3G, which is a potent anti-HIV enzyme, generate stop codons and lead to HIV-1 inactivation. Studies have shown that APOBEC3 enzymes can also induce sub-lethal levels of mutations that lead to HIV-1 diversification and drug resistance. Mutations inflicted by different variants of APOBEC3 enzymes vary substantially in terms of both their extent and sequence context. For example, APOBEC3H haplotype II often induces many G>A mutations. By contrast, APOBEC3H haplotype I induces little or no changes in the HIV-1 genome. Analysis of all reported HIV-1 sequences from ~37,000 patients show that the extent and pattern of viral mutagenesis by APOBEC3 enzymes are highly donor-specific. It is hypothesized that variations in both APOBEC3 and HIV-1 genes are responsible for the observed differences in viral mutation profiles. The preliminary data suggest these variations create a complex cascade of patient-specific interactions between HIV- 1 and APOBEC3 enzymes underlying HIV-1 health disparities including responses to antiretroviral treatments. This proposal aims to integrate diverse viral and host datasets and use a combination of computational and experimental techniques to identify the molecular determinates of differential viral mutagenesis, and elucidate their roles in patient-specific responses to antiretroviral therapies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $822,404 )
2025	2025	TEXAS BIOMEDICAL RESEARCH INSTITUTE	8715 W MILITARY DR	SAN ANTONIO	TX	78227	BEXAR	USA	Allergy and Infectious Diseases Research	000	2	5/9/2025	NON-COMPETING CONTINUATION	$822,404
														Subtotal = $822,404

Issue Date FY: 2024 ( Subtotal = $856,769 )
2024	2024	TEXAS BIOMEDICAL RESEARCH INSTITUTE	8715 W MILITARY DR	SAN ANTONIO	TX	78227	BEXAR	USA	Allergy and Infectious Diseases Research	000	1	6/21/2024	NEW	$856,769
														Subtotal = $856,769

Grand Total All Awards = $1,679,173

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme

Award Number: R01AI179465

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/21/2024

PERIOD OF PERFORMANCE END DATE: 04/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer